December 27 marks the International Day of Epidemic Preparedness, a day to reflect on the critical importance of being ready to face epidemics, both current and future. This annual observance, established by the United Nations, emphasizes the need for education, awareness, and robust health systems to address the challenges posed by infectious diseases.

In recent years, the world has witnessed how globalization and climate change have intensified the spread of infectious diseases. One such emerging threat is the West Nile Virus (WNV), a mosquito-borne virus that has significant impacts on human and animal health. While most human infections are asymptomatic, WNV can cause severe neurological disease in some cases. The virus’s spread is facilitated by mosquitoes and birds, and its growing prevalence underscores the importance of preparedness.

At LWNVIVAT, we are contributing to epidemic preparedness by advancing the development of a recombinant vaccine and therapeutic antibodies against WNV. Our work aims to provide effective tools to prevent and treat infections, addressing the lack of specific treatments currently available for this disease. By focusing on innovative scientific solutions, we strive to protect vulnerable populations and mitigate the impact of WNV epidemics.

The International Day of Epidemic Preparedness reminds us that proactive measures and partnerships are essential to combatting global health threats. Research initiatives like LWNVIVAT exemplify how science can serve as a cornerstone for preparedness, enabling societies to respond swiftly and effectively to emerging challenges.

Today, let us reaffirm our commitment to fostering scientific research, raising awareness, and strengthening health systems to ensure a safer, healthier future for all.